Table 3 Multivariate analysis of the factors associated with in hospital mortality for proximal humerus fracture among men and women and stratified by type 2 diabetes in Spain. 2001–2013

Total

No T2DM

T2DM

No T2DM

T2DM

Men

Women

Age groups (years)

65–74

1

1

1

1

1

1

75–79

1.45(0.86–2.43)

1.86(0.69–5.04)

2.07(1.24–3.46)

1.68(0.87–3.25)

1.56(0.98–2.47)

1.92(1.28–2.89)

80–84

1.08(0.60–1.95)

1.67(0.57–4.88)

3.25(1.99–5.31)

2.48(1.30–4.73)

1.19(0.71–2.01)

3.05(2.06–4.52)

85–89

3.73(2.22–6.26)

5.14(1.89–13.98)

5.40(3.31–8.82)

3.43(1.71–6.91)

4.25(2.67–6.78)

4.98(3.34–7.43)

>90

2.80(1.31–5.97)

N/A

9.69(5.75–16.35)

7.72(3.72–16.02)

2.56(1.25–5.26)

9.90(6.44–15.21)

Charlson Comorbidity Index

0

1

1

1

1

1

1

1

2.71(1.77–4.15)

2.52(1.0–6.35)

3.51(2.59–4.75)

3.95(2.43–6.44)

2.79(1.90–4.10)

3.70(2.86–4.78)

≥ 2

6.29(3.85–10.28)

5.65(2.10–15.18)

6.7(4.47–10.10)

9.64(5.42–17.17)

6.66(4.30–10.32)

8.26(5.93–11.52)

In-hospital complications

No

1

1

1

1

1

1

Yes

11.09(6.96–17.68)

10.10(4.21–24.25)

8.55(6.06–12.06)

6.20(3.68–10.45)

11.70(7.77–17.65)

8.21(6.15–10.96)

Arthroplasty

Yes

1

1

1

1

1

1

No

9.36(2.88–30.42)

3.32(0.41–26.58)

3.16(1.81–5.54)

2.40(1.12–5.15)

7.14(2.57–19.83)

2.64(1.68–4.15)

ORIF

Yes

1

1

1

1

1

1

No

5.72(2.73–11.96)

1.55(0.58–4.13)

4.51(2.58–7.89)

4.62(1.96–10.88)

3.67(2.07–6.52)

4.12(2.58–6.59)

CRIF

Yes

1

1

1

1

1

1

No

2.46(1.45–4.19)

2.63(0.73–9.38)

2.08(1.42–3.04)

2.51(1.35–4.67)

2.44(1.5–3.98)

2.17(1.57–3.01)

Year of discharge

0.95(0.90–0.99)

0.82 (0.73–0.91)

0.93(0.90–0.97)

0.90(0.85–0.97)

0.92(0.88–0.97)

0.93(0.90–0.96)

T2DM status

No

NA

NA

NA

NA

1

1

Yes

NA

NA

NA

NA

0.92(0.60–1.41)

1.67(1.29–2.15)